Effectiveness and safety of tocilizumab for COVID-19: a systematic review and meta-analysis of randomized clinical trials

BACKGROUND: Tocilizumab is an anti-human interleukin 6 receptor monoclonal antibody that has been used to treat coronavirus disease 2019 (COVID-19). However, there is no consensus on its efficacy for the treatment of COVID-19. OBJECTIVE: To evaluate the effectiveness and safety of tocilizumab for tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeida, Paula Ribeiro Lopes, Person, Osmar Clayton, Puga, Maria Eduarda dos Santos, Giusti, Maria Fernanda, Pinto, Ana Carolina Pereira Nunes, Rocha, Aline Pereira, Atallah, Álvaro Nagib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Paulista de Medicina - APM 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005468/
https://www.ncbi.nlm.nih.gov/pubmed/36102463
http://dx.doi.org/10.1590/1516-3180.2022.0170.R1.01072022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005468/
https://www.ncbi.nlm.nih.gov/pubmed/36102463
http://dx.doi.org/10.1590/1516-3180.2022.0170.R1.01072022

Ejemplares similares